December 10 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO Ognyan Donev has acquired 8,511 shares in the company at a weighted average price per share of 3.425 levs ($1.96/1.76 euro).
Donev acquired the shares through deals on the Bulgarian Stock Exchange on December 9, Sopharma said in a bourse filing.
The 8,511 shares are equal to a 0.006% stake in Sopharma.
At the end of September, Donev held a stake of below 5% in Sopharma, according to the company's most recent interim financial statement.
However, Ognyan Donev is indirectly the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.
As at 9:20 CET on Tuesday, Sopharma shares traded 0.29% higher at 3.44 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)